T
Terry C. Orton
Researcher at AstraZeneca
Publications - 31
Citations - 4880
Terry C. Orton is an academic researcher from AstraZeneca. The author has contributed to research in topics: Gene & Carcinogenesis. The author has an hindex of 17, co-authored 31 publications receiving 4591 citations. Previous affiliations of Terry C. Orton include Imperial College London.
Papers
More filters
Journal ArticleDOI
Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity
TL;DR: The identity of Alamar Blue is shown as resazurin, a very simple and versatile way of measuring cell proliferation and cytotoxicity that presents numerous advantages over other cytot toxicity or proliferation tests but there are several drawbacks to the routine use.
Journal ArticleDOI
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity.
TL;DR: This work has identified point mutations in the remaining allele of 25% of human hepatocellular carcinomas (HCCs) with LOH that give rise to truncated receptor protein and significant amino acid substitutions, and provide evidence that the M6P/IGF2R gene functions as a tumour suppressor in human liver carcinogenesis.
Journal ArticleDOI
Novel Imprinted DLK1/GTL2 Domain on Human Chromosome 14 Contains Motifs that Mimic Those Implicated in IGF2/H19 Regulation
TL;DR: Evidence is provided that a common mechanism and domain organization may be used for juxtapositioned, reciprocally imprinted genes on human chromosome 14q32, and many of the predicted structural and regulatory features of the DLK1/GTL2 domain are highly analogous to those implicated in IGF2/H19 imprint regulation.
Journal ArticleDOI
Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid)
TL;DR: The molecular weights and spectral properties of these cytochrome P-450 fractions are reported, along with the phenobarbitone-induced form of the enzyme and the nature of the cytochromes induced by clofibrate pretreatment are discussed in the terms of possible haemoprotein heterogeneity.
Journal ArticleDOI
Inhibitors of 3-Hydroxy-3-Methylglutaryl–CoA Reductase Reduce Receptor-Mediated Endocytosis in Opossum Kidney Cells
James E. Sidaway,Robert G. Davidson,Fergus McTaggart,Terry C. Orton,Robert C. Scott,Graham J. Smith,Nigel J. Brunskill +6 more
TL;DR: Data establish the possibility in principle that inhibition of HMG-CoA reductase by statins in proximal tubule cells may reduce tubular protein reabsorption and cause reduced prenylation and thereby decreased function of one or more GTP-binding proteins.